SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cor Therapeutics Inc. (CORR)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
712 22 0 CORR
Emcee:  Joyce Yee Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
687COR Therapeutics warns of Q3 profit shortfall (UPDATE: adds details, company comkeokalani'nui-10/3/2001
686The cost savings numbers for Integrilin versus ReoPro are elucidated in this stutuck-8/19/2001
685COR Therapeutics, Inc. Reports Profitable Second Quarter Driven by 60 Percent YeSemiBull-7/17/2001
684Hi tuck, Your views sound sensible, well-reasoned and seasoned. Semi sees my cRaymond Duray-7/13/2001
683If I may bull in, I think the financing may be a prelude to a licensing deal or tuck-7/13/2001
682Dilutive financing for $50M? Nope.SemiBull-7/13/2001
681Hi SemiBull, Do you see this, as I do, as a dilutive financing indicating thatRaymond Duray-7/12/2001
680COR Therapeutics, Inc. Announces the Sale of Additional $50 Million of Notes bizSemiBull-7/11/2001
679>> Corr Target is currently $40.00. << Whose target? I agree that tRCMac-7/10/2001
678Corr Target is currently $40.00. I think after July release of Sales it will beBill Habeck-7/10/2001
677I see Thanks a lot, I did not know what to think I'm getting too much suspicYxY-6/13/2001
676Its the standard disclaimer. If there was something more material, believe me, Londo-6/13/2001
675Thanks where does this come from ?YxY-6/13/2001
674Stock splits, spin-offs, and the like would adjust the price.Londo-6/13/2001
673I've been going through the sec filling but I did not found how this convertYxY-6/13/2001
672ESPRIT Study Results and Dosing Regimen Approved for Inclusion in U.S. PrescribiSemiBull-6/11/2001
671COR Therapeutics, Inc. Announces Proposed $175 Million Convertible Senior Notes SemiBull-6/4/2001
670Hmm....seems like people are disappointed more easily because study showed an ovSemiBull-5/23/2001
669More positives on Integrilin...wondering when the stock will start to really runSemiBull-5/23/2001
668Study Lauds CORR's Angioplasty Drug dailynews.yahoo.comSemiBull-5/15/2001
667ON The Move: Analyst: CORR's Integrilin Top Drug in Its Class biz.yahoo.comSemiBull-5/7/2001
666Wow, that's fascinating.. Usually people like to pump and dump stocks with Londo-5/4/2001
665I had some guy with a Brooklyn accent cold call me trying to get me to put moneyCharles H. Waldron-5/3/2001
664<i>Where is everybody?</i> They're probably still sleeping. DoLondo-4/17/2001
663Where is everybody? COR makes its numbers: >>COR Therapeutics posts 1st-qtuck-4/17/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News